Jongchan Kim

Yonsei University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index3.5kcitations64works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(17), Ubiquitin and proteasome pathways(11), MicroRNA in disease regulation(9), Cancer-related molecular mechanisms research(7), Cancer-related Molecular Pathways(7)

Publications64 total

147 Metabolomic signature predicts recurrence in adjuvant immunotherapy candidates with clear cell renal cell carcinomas
Regular and Young Investigator Award Abstracts·2025Open Access
Enhanced efficacy of glycoengineered rice cell‐produced trastuzumab
Plant Biotechnology Journal·2024· 5 citedOpen Access
<scp>OTUD6A</scp> orchestrates complex modulation of <scp>TEAD4</scp>‐mediated transcriptional programs
FEBS Letters·2024· 1 citedOpen Access
USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity
Biomolecules·2023· 4 citedOpen Access
A Study on the Classification of the Term “Wuyi”
2023
OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1
Biomolecules·2023· 4 citedOpen Access
Supplementary Figure Legends from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Figures S1-S11 from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Materials and Methods from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Figures S1-S11 from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Data from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Data from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Materials and Methods from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Figure Legends from Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
2023Open Access
Supplementary Tables and Figures from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
Supplementary Materials and Methods from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
Supplementary Tables and Figures from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
Data from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
Supplementary Materials and Methods from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
Supplementary Figure Legends from AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Li Ma(13), Yutong Sun(8), Mien‐Chie Hung(7), Sarki A. Abdulkadir(7), Zhenna Xiao(6), Peijing Zhang(6), Hyemin Lee(5), Boyi Gan(5), Fan Yao(5), Yumeng Wang(5), Ashley N. Siverly(5), Zhicheng Zhou(5), Weiya Xia(5), Longfei Huo(5), Long‐Yuan Li(5), Chien‐Chen Lai(5), Hirohito Yamaguchi(5), Dung‐Fang Lee(5), Chao‐Kai Chou(5), Jung-Mao Hsu(5)